Prometic to conduct PBI-4050 ’s Phase II/III trial for IPF in US

Canada-based Prometic Life Sciences has secured investigational new drug (IND) approval from the US Food and Drug Administration (FDA) to evaluate its drug candidate PBI-4050 in a Phase II/III clinical trial to treat idiopathic pulmonary fibrosis (IP …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news

Related Links:

Every organization knows its intellectual property is incredibly valuable — potentially it’s the most valuable data any company has. For manufacturers in the medtech space, it’s often the lifeblood of the company. IP is also one of your most vulnerable assets and can put you at risk from hostile insiders and external attackers. Breaches come with a high price tag. They cost companies money and time, and can damage reputations for years. Company executives, corporate boards and other stakeholders are waking up to the dangers posed by cybercriminals and demanding action. ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ News - Category: General Medicine Source Type: research
Source: BMJ News - Category: General Medicine Source Type: research
Fifty years ago, in a golden moment of television comedy shows, Rowan &Martin’s Laugh-In program regularly featured “The Flying Fickle Finger of Fate” award.  Wikipedia says it “recognized actual dubious achievements by public individuals or institutions.” Do a Google search.  You’ll quickly see how popular this award became. Yes, I’m dating myself by going back 50 years.  But mine is the generation that often becomes obsessed with being given “the finger” by doctors for digital rectal exams (DRE) looking for prostate cancer. And it is in that context...
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Conditions Mainstream media Oncology/Hematology Source Type: blogs
More News: Canada Health | Clinical Trials | Food and Drug Administration (FDA) | Investigational New Drugs | Pharmaceuticals